Global CDK 4/6 Inhibitor Drugs Market Outlook 2023-2035: A USD 66.63 Billion Market by 2035, Up From USD 9.03 Billion in 2022 [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
The global CDK 4/6 inhibitor drugs market is anticipated to grow with a CAGR of 16.78% over the forecast period 2022 - 2035. Factors such as the surge in the cases of breast cancer among women, followed by the rising development of combination therapies including CDK 4/6 inhibitor drugs are projected to drive the growth of the market in the coming years. Additionally, the rising advancement in drug development is also expected to boost the market growth. The market is estimated to garner a revenue of nearly USD 66.63 billion by the end of 2035, up from a revenue of about USD 9.03 billion in the year 2022. The global CDK 4/6 inhibitor drugs market is segmented into numerous segments, which include segmentation by patient, drug type, end-user, and by region. By end user, the market is segmented into hospitals, clinics, research laboratories, and retail pharmacies. By the end of 2035, the hospital segment is anticipated to garner the largest revenue of around USD 38.18 billion, up f
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Why Eli Lilly Stock Jumped by 4% Today [Yahoo! Finance]Yahoo! Finance
- Lilly Declares Second-Quarter 2024 DividendPR Newswire
- Lilly (LLY) Reliance on International Sales: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Investors Pile Into Amgen in Search of Next Obesity Drug Payout [Yahoo! Finance]Yahoo! Finance
- 3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 5/3/24 - Form SD
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- LLY's page on the SEC website